Alkermes

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Alkermes and other ETFs, options, and stocks.

About ALKS

Alkermes Plc is a global biopharmaceutical company, which engages in the business of developing, manufacturing, and commercializing medicines designed to address unmet medical needs of patients in major therapeutic areas such as alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Its proprietary products include ARISTADA, ARISTADA INITIO, LYBALVI, and VIVITROL. 

CEO
Richard F. Pops
CEORichard F. Pops
Employees
1,800
Employees1,800
Headquarters
Dublin, Dublin
HeadquartersDublin, Dublin
Founded
2011
Founded2011
Employees
1,800
Employees1,800

ALKS Key Statistics

Market cap
5.28B
Market cap5.28B
Price-Earnings ratio
15.84
Price-Earnings ratio15.84
Dividend yield
Dividend yield
Average volume
1.54M
Average volume1.54M
High today
$33.26
High today$33.26
Low today
$31.77
Low today$31.77
Open price
$31.90
Open price$31.90
Volume
1.65M
Volume1.65M
52 Week high
$36.32
52 Week high$36.32
52 Week low
$25.17
52 Week low$25.17

Stock Snapshot

As of today, Alkermes(ALKS) shares are valued at $33.26. The company's market cap stands at 5.28B, with a P/E ratio of 15.84.

During the trading session on 2026-02-20, Alkermes(ALKS) shares reached a daily high of $33.26 and a low of $31.77. At a current price of $33.26, the stock is +4.7% higher than the low and still 0.0% under the high.

Trading activity shows a volume of 1.65M, compared to an average daily volume of 1.54M.

The stock's 52-week range extends from a low of $25.17 to a high of $36.32.

The stock's 52-week range extends from a low of $25.17 to a high of $36.32.

ALKS News

Simply Wall St 5d
Is It Time To Reassess Alkermes After Mixed Share Price Performance?

If you are wondering whether Alkermes at around US$33.16 is offering good value right now, this article will walk through what the numbers actually suggest. Th...

Is It Time To Reassess Alkermes After Mixed Share Price Performance?
Simply Wall St 6d
Assessing Alkermes Valuation After Recent Share Price Swings

Advertisement Alkermes overview and recent share performance Alkermes (ALKS) has drawn investor interest after recent trading showed a 4.6% one day decline, a...

Assessing Alkermes Valuation After Recent Share Price Swings

Analyst ratings

81%

of 16 ratings
Buy
81.3%
Hold
18.8%
Sell
0%

People also own

Based on the portfolios of people who own ALKS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.